Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study

Conclusions: In the Finnish unselected population, breast cancer is fatal in 1 of 10 patients. Our data imply that this risk is prevalent in 1 of 20 patients with history of HT use. This is an important message for women considering or already using HT.

Source: Menopause - October 28, 2016 Category: OBGYN Tags: Original Articles Source Type: research